Meeting Hub - ASCP - American Society of Clinical Psychopharmacology

Explore Our Meeting

ASCP organizes one major meeting per year. The ASCP Annual Meeting brings together over 1200 academic and industry investigators, research pharmacists, clinicians and representatives from regulatory agencies to discuss newer treatments and facilitate collaborations.

Registration Dates & Rates

In-Person Registration Rates:

REGISTRATION CATEGORIES	Early Bird *Before March 25, 2026*	Standard *March 26 - May 14, 2026*	Late *Beginning May 15, 2026*
ASCP Member	$400	$425	$450
Academic	$525	$550	$625
Clinician	$525	$550	$625
Fully Retired	$260	$260	$260
Government	$475	$500	$575
Industry	$700	$875	$950
New Investigator Alumni	$250	$250	$250
Trainee/Student	$160	$160	$160
EMA	Please contact info@ascpp.org for more information regarding the EMA rate.
FDA	Please contact info@ascpp.org for more information regarding the FDA rate.

* All registration types will be verified upon submission of your registration and are subject to change if incorrectly selected.
♦ The NIA Alumni rate is only valid for 7 years after the NIA award is received (2020 through 2026).

Should you have a disability and need special accommodations, please contact the ASCP Executive Office at info@ascpp.org or 615-649-3085.

ADDITIONAL REGISTRATION ITEMS
CME, CE, or MOC	Attendees requesting CME, CE, or MOC have the option to purchase now or during the post conference evaluation process. If purchased now, you will be able to attest your hours following the conference.	$40
Guest Reception Ticket		$80
2026 Annual Meeting T-Shirt		$15

Cancellation Policy

Meeting registration fees will be refunded (less $75 process fee) if the Executive Office receives written notice to info@ascpp.org by Friday, April 24, 2026.

Registration Descriptions - All registration types will be verified upon submission of your registration and are subject to change if incorrectly selected.

ASCP Membership is available to holders of doctoral degrees whose interests are to advance the science, practice, and education of clinical psychopharmacology and other related innovative treatment modalities.
Associate Membership is available to those whose interests are to advance the science, practice, and education of clinical psychopharmacology and other related innovative treatment modalities, but who do not currently hold a doctoral degree and who do not meet the criteria for Resident/Trainee Membership.
Academic / Clinician is for those attendees who are employed by an academic institution or are practicing clinicians in a private or not-for-profit organization.
Government is for attendees who are employed by a government agency.
Industry is for attendees who are part-time or full-time employees with a for-profit research organization.
Fully Retired is for attendees that do not see patients (other than as an unpaid volunteer) and have no professional income from any source (including consulting fees or honoraria from companies, etc.).
New Investigator Alumni is for past New Investigator Awardees. This is only valid for 7 years after the NIA award is received (NIAs from 2018-2024)
Trainee and Student registration is for those attendees who are in a training position (not a full time permanent position). To qualify for the Trainee / Student rate, the attendee MUST submit a letter from their training director or department head verifying that they are in an approved training program with a specified end date.

Important Submission Dates

Submission Type	Deadline	Status	Submission Information
Panels & Workshops Chair & Individual Presenter Proposals	November 18, 2025	*CLOSED*	Call For Proposals Panels & Workshops Submission Guidelines
Donald Klein Lifetime Achievement Award	January 28, 2026	*OPEN*	Call For Proposals Award Flyer
Paul Wender Best Paper in The Journal of Clinical Psychiatry Award	January 28, 2026	*OPEN*	Call For Proposals Award Flyer
Henry Nasrallah Award for Excellence in Clinical Psychopharmacology Education	January 28, 2026	*OPEN*	Call for Proposals Award Flyer
Posters & Individual Research Reports	January 28, 2026	*OPEN*	Call For Proposals Posters & IRR Submission Guidelines
New Investigator Awards	January 28, 2026	*OPEN*	Call For Proposals NIA Submission Guidelines
Pharmaceutical Pipeline Presentations	February 19, 2026	OPEN	Call For Proposals Pharmaceutical Pipeline Submission Guidelines
Late-Breaking Posters	March 13, 2026	OPENING FEBRUARY 25, 2026	Late-Breaking Submission Guidelines

Award Deadlines

The following award nominations and applications are due January 28, 2026.

Donald Klein Lifetime Achievement Award

Paul Wender Best Paper in The Journal of Clinical Psychiatry Award

Henry Nasrallah Award for Excellence in Clinical Psychopharmacology Education

Nina Schooler Early Career Research Award

Award winners will be notified early spring.

Submit Your Science

Quick Links

Submissions

Submissions are open for the 2026 ASCP Annual Meeting. Click here for more information.

New Investigator Award (NIA)

Submissions for the 2026 NIA Program are open until January 28, 2026.

Meeting Sponsorships

ASCP hopes to partner with you for the 2026 Annual Meeting. Click here for more information on sponsorships.

Annual Meeting Awards

ASCP believes in celebrating excellence and success. We offer several awards each year.

Past Meetings

Explore our past annual meetings here.

Hosting a Small Meeting

Small Meeting submissions are open for the 2026 ASCP Annual Meeting. Please click the button below for more information.

Learn More

Code of Conduct

Read about ASCP's code of conduct here.

Learn More

About the Meeting

The ASCP Annual Meeting is the premier meeting each year in the field of psychopharmacology. Bringing together representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies, and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Program Committee for the Annual Meeting chaired by Drs. Tiffany Farchione and Carlos Blanco including representatives from the ASCP Community, FDA, EMA, NIMH, NIDA, NIAAA, and the academia members, lead the direction of the meeting. The Review Subcommittee, under the leadership of Drs. Manish Jha and Dan Iosifescu, are responsible for the review of all program submissions. To ensure the meeting includes the needs of our loyal pharmaceutical industry members, we are excited to announce the launch of the ASCP Industry Advisory Council led by Drs. Ross Baker and Julie Adams.

The ASCP Annual Meeting brings together over 900 academic and industry investigators, research pharmacists, and clinicians, including competitively selected New Investigator Awardees. ASCP is joined by federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism, (NIAAA) and the Food and Drug Administration (FDA) to organize a program that emphasizes the presentation of information that has not been previously published or presented.

In recent years, the ASCP Annual Meeting focus has been expanded to address a number of timely issues relevant to clinical research in psychiatry, including the translation of research into practice, the importance of regulatory issues, and pharmacogenetics and other means to personalizing interventions.

Register for the 2026 Annual Meeting